Cargando…

Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk

OBJECTIVE: To investigate the effect of low blood glucose on thrombin generation and fibrin clot properties in type 2 diabetes (T2DM). METHODS: In 165 patients with T2DM and high cardiovascular risk, we measured ex vivo plasma fibrin clot permeation [K(s)], turbidity and efficiency of fibrinolysis i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gajos, Grzegorz, Konieczynska, Malgorzata, Zalewski, Jaroslaw, Undas, Anetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432887/ https://www.ncbi.nlm.nih.gov/pubmed/25928628 http://dx.doi.org/10.1186/s12933-015-0207-2

Ejemplares similares

Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long‐term follow‐up study
por: Bryk, Agata Hanna, et al.
Publicado: (2021)

Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia
por: Mastalerz, Lucyna, et al.
Publicado: (2015)

Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception
por: Piróg, Magdalena, et al.
Publicado: (2019)

Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease
por: Bochenek, Maciej, et al.
Publicado: (2012)

Polyhedrocytes in blood clots of type 2 diabetic patients with high cardiovascular risk: association with glycemia, oxidative stress and platelet activation
por: Gajos, Grzegorz, et al.
Publicado: (2018)

Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary Syndrome
por: Undas, Anetta, et al.
Publicado: (2008)

Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice
por: Ząbczyk, Michał, et al.
Publicado: (2023)

Increased Oxidation as an Additional Mechanism Underlying Reduced Clot Permeability and Impaired Fibrinolysis in Type 2 Diabetes
por: Lados-Krupa, Anna, et al.
Publicado: (2015)

Unexplained thrombosis of the aortic arch with distal embolization in a patient with altered fibrin clot properties
por: Ciurus, Tomasz, et al.
Publicado: (2012)

Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism
por: Ząbczyk, Michał, et al.
Publicado: (2021)

Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes
por: Ząbczyk, Michał, et al.
Publicado: (2021)

Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence
por: Undas, Anetta
Publicado: (2017)

Thrombin generation and fibrin clot structure after vitamin D supplementation
por: Blondon, Marc, et al.
Publicado: (2019)

Relationship between polyunsaturated fatty acid composition in serum phospholipids, systemic low-grade inflammation, and glycemic control in patients with type 2 diabetes and atherosclerotic cardiovascular disease
por: Poreba, Malgorzata, et al.
Publicado: (2018)

Omega-3 Polyunsaturated Fatty Acids Increase Plasma Adiponectin to Leptin Ratio in Stable Coronary Artery Disease
por: Mostowik, Magdalena, et al.
Publicado: (2013)

Delayed Thrombin Generation Is Associated with Minor Bleedings in Venous Thromboembolism Patients on Rivaroxaban: Usefulness of Calibrated Automated Thrombography
por: Zalewski, Jaroslaw, et al.
Publicado: (2020)

Plasma Fibrin Clot Properties as Determinants of Bleeding Time in Human Subjects: Association with Histidine-Rich Glycoprotein
por: Szułdrzyński, Konstanty, et al.
Publicado: (2020)

Accelerated fibrin clot degradation is associated with arterial thromboembolism in patients following venous thrombosis: a cohort study
por: Mrozinska, Sandra, et al.
Publicado: (2021)

Elevated lipoprotein(a) as a new risk factor of cerebral venous sinus thrombosis: association with fibrin clot properties
por: Skuza, Anna Aleksandra, et al.
Publicado: (2018)

Restenosis is associated with prothrombotic plasma fibrin clot characteristics in endovascularly treated patients with critical limb ischemia
por: Nowakowski, Tomasz, et al.
Publicado: (2019)

Free Fatty Acids Modulate Thrombin Mediated Fibrin Generation Resulting in Less Stable Clots
por: Tanka-Salamon, Anna, et al.
Publicado: (2016)

Predictors of neutrophil extracellular traps markers in type 2 diabetes mellitus: associations with a prothrombotic state and hypofibrinolysis
por: Bryk, Agata H., et al.
Publicado: (2019)

Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype
por: Natorska, Joanna, et al.
Publicado: (2023)

Elevated plasma factor XI predicts cardiovascular events in patients with type 2 diabetes: a long-term observational study
por: Paszek, Elżbieta, et al.
Publicado: (2023)

Anticoagulants and the Propagation Phase of Thrombin Generation
por: Orfeo, Thomas, et al.
Publicado: (2011)

Differences in plasma fibrin clot composition in patients with thrombotic antiphospholipid syndrome compared with venous thromboembolism
por: Stachowicz, Aneta, et al.
Publicado: (2018)

Faster fibrin clot degradation characterizes patients with central pulmonary embolism at a low risk of recurrent peripheral embolism
por: Kupis, Robert W., et al.
Publicado: (2019)

Elevated Lactate Levels in Acute Pulmonary Embolism Are Associated with Prothrombotic Fibrin Clot Properties: Contribution of NETs Formation
por: Ząbczyk, Michał, et al.
Publicado: (2020)

Specific changes in circulating cytokines and growth factors induced by exercise stress testing in asymptomatic aortic valve stenosis
por: Kolasa-Trela, Renata, et al.
Publicado: (2017)

Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes
por: Poreba, Malgorzata, et al.
Publicado: (2017)

Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality risk
por: Ząbczyk, Michał, et al.
Publicado: (2020)

P1699: ANTITHROMBIN DEFICIENCY IS ASSOCIATED WITH PROTHROMBOTIC FIBRIN CLOT PHENOTYPE
por: Zabczyk, M., et al.
Publicado: (2022)

Thrombin based gelatin matrix and fibrin sealant mediated clot formation in the presence of clopidogrel
por: Dwyer, Joseph F, et al.
Publicado: (2014)

Neutrophil-activating Peptide 2 as a Novel Modulator of Fibrin Clot Properties in Patients with Atrial Fibrillation
por: Ząbczyk, Michał, et al.
Publicado: (2023)

Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells
por: Smadja, David M, et al.
Publicado: (2008)

Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulation
por: Zalewski, Jarosław, et al.
Publicado: (2016)

Optimization of quantitative proteomic analysis of clots generated from plasma of patients with venous thromboembolism
por: Stachowicz, Aneta, et al.
Publicado: (2017)

Fixation of split-thickness skin graft using fast-clotting fibrin glue containing undiluted high-concentration thrombin or sutures: a comparison study
por: Han, Hyun Ho, et al.
Publicado: (2016)

Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics
por: Pretorius, Etheresia, et al.
Publicado: (2015)

Thrombin‐generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause
por: Hofer, Stefanie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s2bso927kuoga9e3mfscqohbl3